- ADAM, a new implantable, non-hormonal male contraceptive, has proven effective for 24 months in clinical trials.
- The water-soluble hydrogel implant is placed in the sperm ducts, preventing sperm from mixing with semen.
- The implant is designed to be reversible and break down after a set time, restoring fertility.
- Trials showed no sperm in the semen of participants after 24 months, with no serious side effects reported.
- Contraline, the company behind ADAM, will begin phase two clinical trials in Australia later this year in what it described as a “major milestone”.
IN FULL
Male non-hormonal contraceptive implant shown to work for 24 months in trials